Public Alert No. 33/2023 – Alert on the Ban of Sheesha Beauty Cream and Dona White Extra Whitening Lotion by the EU due to Mercury content
November 2, 2023,
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of the ban of Sheesha Beauty Cream and Dona White Extra Whitening Lotion by the EU.
The products were tested against European standards and did not comply with the Cosmetic Products Regulation as they are said to contain mercury which when accumulated in the body and can damage the kidneys, brain and nervous system. Additionally, it may affect reproduction and the unborn child. As a result, a ban on the import of the products have been placed by some regulatory and public authorities, in the EU.
Product details
The details of the product are as follows;
| Product Name | Sheesha Beauty Cream | Extra Whitening Lotion |
| Product Brand | Sheesha | Dona White |
| Product Manufacturer | REEVE COSMETICS, NON | Unknown |
| Barcode | 3254896565854 | Nil |
| Product Category | Cosmetics | Cosmetics |
| Product description | Skin lightening cream | Skin lightening cream |
| Mercury Content | Measured value: 17400 mg/kg | Measured value: 1.33 mg/kg |
| Packaging description | Cardboard box | Gold plastic bottle |
| Notifying Country | Sweden | Sweden |
| Product Country of Origin | Pakistan | Italy |
| Product Photo |  |
 |
Although these products are not in NAFDAC database, importers, distributors, retailers and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale and use of the above-mentioned product. The product authenticity and physical condition should be carefully checked. Members of the public in possession of the product should discontinue sale or use and submit stock to the nearest NAFDAC office.
Healthcare professionals and consumers are advised to report any suspicion of adverse reaction, substandard and falsified regulated products to the nearest NAFDAC office on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng.
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of the products to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng
NAFDAC……..Customer-focused, Agency-minded!!!
Signed Management